Search

everythinglearnresearchcommunity

for

Search:↓

Scopolin and scopoletin from Merremia peltata leaves may help treat hair loss and showed promising results in rabbit tests.

The document concludes that targeting 5α-reductase, the androgen receptor, and hair growth genes, along with using compounds with anti-androgenic properties, could lead to more effective hair loss treatments.

Polymeric nanohydrogels show potential for skin drug delivery but have concerns like toxicity and regulatory hurdles.

Hesperidin protects rat testicles from finasteride damage and improves sperm health.

Iron oxide nanoparticles improve skin penetration and drug release for hair loss treatment.

Created microspheres show potential for safe and effective use in prostate artery embolization.

Urologists should monitor mental health in patients taking finasteride due to potential links to suicidal thoughts, adjusting dosage or stopping use if necessary. More research is needed to confirm if finasteride causes these thoughts.

Understanding hair biology is key to developing better treatments for hair and scalp issues.

Nanostructured delivery systems could potentially improve hair loss treatment by targeting drugs to hair follicles, reducing side effects and dosage, but the best size, charge, and materials for these systems need further investigation.

Cyclodextrins improve finasteride's solubility and bioavailability for hair loss treatment.

Chitosan-coated nanoparticles improve skin delivery of hair loss treatments with fewer side effects.

Propylene glycol and ethanol increase finasteride skin absorption, sodium lauryl sulfate doesn't.

New treatments for prostate cancer and BPH show promise, including novel compounds that target hormone synthesis and response.

Finasteride irreversibly affects human steroid 5α-reductase 2, providing insight into its catalytic mechanism and disease-related mutations.

Electrospun nanofibers might be a promising new treatment for hair loss.

Dissolving microneedles show promise for delivering medication through the skin but face challenges like manufacturing complexity and regulatory hurdles.

Natural herbal compounds might treat certain medical conditions by reducing DHT levels, but more research is needed to confirm their effectiveness and safety.

New method accurately measures finasteride and M3 in urine, helping evaluate pharmacokinetics.

Finasteride may affect PNMT, causing side effects.

Finasteride's molecular and crystal structures help develop new drug formulations.

Compound 4 is a promising treatment for hair loss with low toxicity.

Finasteride-loaded microemulsions can effectively enhance skin delivery for treating hair loss.

Solidified SEDDS improve drug stability and bioavailability better than liquid SEDDS.

Finasteride microspheres help reduce hair loss for up to eight weeks with fewer side effects.

Nanotechnology improves hair care products by enhancing ingredient stability, targeting treatment, and reducing side effects, but more research on its toxicity is needed.

Dutasteride is more efficient than finasteride, but individual results vary.

New treatments for enlarged prostate are being developed, some of which may be more effective than current medications.

Optimal long-acting finasteride injection dose found: 16.8 mg, effective for one month.

New compounds show promise for treating hair loss, enlarged prostate, and prostate cancer, with some being more effective and having different side effects than current treatments.

Certain drugs that block specific enzymes can help treat prostate diseases.